Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

IATR.AT

SELL

Athens Medical C.S.A. · Healthcare · Greece · $178M · Avg Vol: $17K/d

24
StockRank
Q
33
V
38
M
44
P/E (TTM)
—
ROE
-4.1%
D/E
1.5x
Dividend %
—
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →
Loading...
PRICE (1M)-0.8%
2.042.062.082.102.13May 7May 28Jun 18
SMA 50SMA 200
Close
$2.04
RSI (14)
30.4
52W High
$2.73
From 52W High
0.7%

SCORE BREAKDOWN

Quality
33
ROIC
3.4%52.0
ROE
-4.1%40.2
GP/Assets
10.1%26.0
Op. Margin
5.6%56.4
FCF/Assets
-1.4%45.5
Piotroski
—28.7
Int. Cover
0.7x40.8
D/E Ratio
1.50x8.6
Current Ratio
0.81x5.8
Value
38
P/E (TTM)
—N/A
EV/EBITDA
16.9x23.6
P/FCF
—N/A
P/B
1.4x68.8
P/S
0.6x91.5
Div Yield
—N/A
Momentum
44
52W High %
75%64.8
RS 6M
-23%53.6
SMA 50/200
0.95x50.3
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
-85%2.7

FUNDAMENTALS

Market Cap
$178M
P/E (Forward)
—
Gross Margin
19.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of IATR.AT are excluded.

TickerCompanyMkt CapStockRankSignal
IATR.ATAthens Medical C.S.A.(you)$178M24SELL
LAVI.ATLavipharm S.A.$309M59HOLD

Peer medians: ROE 10.6% · P/E 51.9x · Gross margin 47.8%

Athens Medical C.S.A. (IATR.AT) — Stock Score Summary

Athens Medical C.S.A. (IATR.AT) has a MoatMap StockRank of 24/100 based on Quality (33/100), Value (38/100), and Momentum (44/100) factor scores. The current signal is SELL.

Key Financial Metrics

Price$2.04
Market Cap$178M
Price/Book1.40
Return on Equity-4.1%
Return on Invested Capital3.4%
Debt/Equity150.38
Gross Margin19.9%
Operating Margin5.6%
Revenue Growth0.8%
Free Cash Flow$-10M

Athens Medical C.S.A. operates in the Medical Care Facilities industry, part of the Healthcare sector (Greece).

Frequently Asked Questions

What is Athens Medical C.S.A.’s (IATR.AT) StockRank?
MoatMap’s StockRank for Athens Medical C.S.A. (IATR.AT) is 24/100, with a Sell signal. It is a composite of Quality (33), Value (38), and Momentum (44) factor ranks across MoatMap’s 20,000+ stock universe.
Does Athens Medical C.S.A. have an economic moat?
Athens Medical C.S.A. (IATR.AT) has a Quality factor score of 33/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Athens Medical C.S.A. a buy, hold, or sell?
MoatMap’s current signal for Athens Medical C.S.A. (IATR.AT) is Sell, based on a StockRank of 24/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Athens Medical C.S.A. in?
Athens Medical C.S.A. (IATR.AT) operates in the Healthcare sector, specifically the Medical Care Facilities industry (Greece).
Browse all ranked stocksIATR.AT deep dive reportAI ChampionsHow we score stocksSense-check another stock